跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
NATZO 4 TABLETS 4MG
Approved
THERAPEUTIC
NATZO 4 TABLETS 4MG
NATCO PHARMA LIMITED - PHARMA DIVISION (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Feb 9, 2018
Approval ID
71ddc83118a89d61
Company
NATCO PHARMA LIMITED - PHARMA DIVISION (INDIA)
Type
Therapeutic
Approval Details
Approval Id
71ddc83118a89d61
Drug Name
NATZO 4 TABLETS 4MG
Product Name
NATZO 4 TABLETS 4MG
Approval Number
SIN15423P
Approval Date
2018-02-09
Registrant
NATCO PHARMA ASIA PTE. LTD.
Licence Holder
NATCO PHARMA ASIA PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
A04AA01
Atc Item Name
ondansetron
Pharma Manufacturer Name
NATCO PHARMA ASIA PTE. LTD.
Active Ingredients
Ondansetron Hydrochloride Dihydrate 5 mg EQV Ondansetron
4 mg
ONDANSETRON HYDROCHLORIDE DIHYDRATE 5 MG EQV ONDANSETRON
4 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 9, 2018
Approval ID
71ddc83118a89d61
Type
Therapeutic
Back to HSA Approvals
NATZO 4 TABLETS 4MG - HSA Drug Approval Details